Paloma Wang

12/31/2024  /  Board of Directors , Capital Markets , Corporate Governance , Diversity , HKEx , Hong Kong , Hong Kong Stock Exchange , Investment Management , Listing Rules , Publicly-Traded Companies , Regulatory Agenda , Risk Management , Shareholders

7/5/2024  /  Asia Pacific , Board of Directors , Capital Markets , Corporate Governance , Diversity , Environmental Social & Governance (ESG) , HKEx , Hong Kong , Hong Kong Stock Exchange , Investment Management , Listing Rules , Proposed Amendments , Publicly-Traded Companies , Regulatory Agenda , Risk Management , Shareholders

4/1/2024  /  Analytics , Antitrust Division , Artificial Intelligence , Board of Directors , Climate Change , Competition , Compliance , Corporate Communications , Corporate Governance , Corporate Social Responsibility , Data Management , Data Protection , Disclosure Requirements , Diversity , Diversity and Inclusion Standards (D&I) , Employer Liability Issues , Employment Litigation , Employment Policies , Environmental Policies , Environmental Social & Governance (ESG) , Hong Kong , International Data Transfers , Machine Learning , Popular , Publicly-Traded Companies , Race Discrimination , Regulatory Requirements , Reporting Requirements , Risk Management , Securities and Exchange Commission (SEC) , State and Local Government , State Legislatures , Technology Sector

4/1/2024  /  Board of Directors , Climate Change , Corporate Communications , Corporate Governance , Diversity , Electronic Data Transmissions , Environmental Social & Governance (ESG) , HKEx , Hong Kong , Hong Kong Stock Exchange , International Standards , Investment , Investors , Publicly-Traded Companies , Regulatory Requirements , Reporting Requirements , Shareholders , Sustainability

3/28/2024  /  Acquisitions , Antitrust Division , Board of Directors , Capital Markets , China , Corporate Entities , Corporate Governance , Environmental Social & Governance (ESG) , Foreign Corporations , Global Market , Investment Management , Legislative Agendas , Mergers , Private Equity , Regulatory Reform , Regulatory Requirements , Risk Management , Shareholders

3/28/2024  /  Asia Pacific , Board of Directors , Capital Markets , China , Corporate Counsel , Corporate Governance , Corporate Officers , Foreign Corporations , Foreign Investment , Investment , Legislative Agendas , Proposed Legislation , Publicly-Traded Companies , Shareholders

3/5/2024  /  Board of Directors , Capital Markets , Corporate Governance , Disclosure Requirements , Environmental Social & Governance (ESG) , Financial Regulatory Reform , Foreign Corporations , HKEx , Hong Kong , Hong Kong Securities and Futures Commission (HKSFC) , Hong Kong Stock Exchange , Initial Public Offering (IPO) , Internal Controls , Listing Rules , Publicly-Traded Companies , Regulatory Agenda

12/14/2022  /  Acquisitions , Anti-Corruption , Antitrust Division , Banking Sector , Big Tech , Board of Directors , Bonds , Borrowers , Capital Markets , Capital Raising , China , Climate Change , Convertible Notes , Corporate Counsel , Corporate Governance , Corporate Restructuring , Creditors , Cross-Border , Cryptocurrency , Digital Assets , Due Diligence , Economic Sanctions , Enforcement , Environmental Social & Governance (ESG) , EU , Executive Compensation , Financial Services Industry , Forum Selection , Investigations , IRS , Lenders , Mergers , Money Laundering , Partnerships , Publicly-Traded Companies , Recessions , Repurchases , Russia , Securities , Securities and Exchange Commission (SEC) , Securities Litigation , Shareholders , Special Purpose Acquisition Companies (SPACs) , Taxation , Technology , UK , Vertical Mergers

7/14/2020  /  Acquisitions , Amended Rules , Biotechnology , Board of Directors , Censures , Corporate Executives , Enforcement Actions , False Statements , Hang Seng China Enterprises Index (HSCEI) , Hang Seng Index (HSI) , HKEx , Hong Kong , Hong Kong Securities and Futures Commission (HKSFC) , Hong Kong Stock Exchange , Internal Controls , Listing Applications , Listing Rules , Medical Devices , Medical Research , Mergers , Misappropriation , Misleading Statements , Pharmaceutical Industry , Publicly-Traded Companies , Sanctions , Secondary Listings , SFC , Shareholders , Takeovers , Weighted Voting Rights (WVR)

1/30/2020  /  Acquisitions , Administrative Procedure Act , Anti-Discrimination Policies , Anti-Harassment Policies , Anti-Kickback Statute , Antitrust Investigations , Appeals , Arbitration Awards , Attorney General , Backstop Agreements , BEPS , BitLicense , Blockchain , Board of Directors , Bonds , Capital Markets , CFIUS , CFTC , Chapter 11 , Claim Preclusion , Class Action , Commercial Bankruptcy , Common Stock , Congressional Investigations & Hearings , Congressional Subpoenas , Consumer Financial Protection Bureau (CFPB) , Cooperation Agreement , Copyright , Corporate Governance , Corporate Restructuring , Corporate Social Responsibility , Corporate Taxes , Corwin Doctrine , Covenant Lite Deals , Creditors , Cross-Border Transactions , DACA , DE Supreme Court , Debt Financing , Debtors , Department of Justice (DOJ) , Dischargeable Debts , Disgorgement , Disparate Impact , Dodd-Frank , Down Rounds , Drug Pricing , EBITDA , Employee Retirement Income Security Act (ERISA) , Employer Liability Issues , Employment Discrimination , Enforcement Actions , Enforcement of Foreign Judgments , Enterprise Act 2002 , Environmental Social & Governance (ESG) , EU , Fair Housing Act (FHA) , Federal Trade Commission (FTC) , FinTech , FIRRMA , Foreign Acquisitions , Foreign Investment , Foreign Issuers , FRCP 23 , General Data Protection Regulation (GDPR) , General Elections , GILTI tax , High-Yield Markets , Hong Kong , Hong Kong Stock Exchange , Individual Accountability , Initial Public Offering (IPO) , Intellectual Property Litigation , Intercreditor Agreements , International Arbitration , International Litigation , IRS , Issue Preclusion , Japan , Joint Venture , Legislative Agendas , Life Sciences , Listing Rules , Litigation Strategies , Make-Whole Premium , Mergers , MFW , Multinationals , National Security , PCAOB , Pharmaceutical Industry , Political Parties , Preferred Shares , Private Offerings , Privately Held Corporations , Proxy Advisory Firms , Publicly-Traded Companies , Refinancing , Regulatory Agenda , Reporting Requirements , SCOTUS , Securities and Exchange Commission (SEC) , Securities Litigation , Separation of Powers , Shareholder Activism , Shareholder Proposals , Shareholders , Split of Authority , State Labor Laws , Stock Drop Litigation , Tax Cuts and Jobs Act , Tax Litigation , Technology Sector , Third-Party Release Agrements , Transparency , UK , UK Brexit , Valuation , White Collar Crimes

1/8/2020  /  Acquisitions , Annual Reports , Beneficial Owner , Board of Directors , Breach of Duty , Censures , Compensation , Complex Corporate Transactions , Conflicts of Interest , Controlling Person , Criminal Convictions , Cross-Border Transactions , Debt Securities , Enforcement Actions , Environmental Social & Governance (ESG) , Failure to Cooperate , Filing Deadlines , Foreign Acquisitions , Foreign Offerings , HKEx , Hong Kong , Hong Kong Securities and Futures Commission (HKSFC) , Hong Kong Securities Clearing Company Limited (HKSCC) , Hong Kong Stock Exchange , Insider Trading , Investment Adviser , Listing Rules , Mandatory Disclosure Rules , Materiality , Publicly-Traded Companies , Regulatory Agenda , Reporting Requirements , Secondary Listings , Shareholder Approval , Trial Court Orders

7/5/2019  /  Accounting Standards , Acquisitions , Audit Policies , Board of Directors , CEOs , China , Conflicts of Interest , Controlling Stockholders , Criminal Prosecution , Disclosure Requirements , Disqualification , Due Diligence , Economic Sanctions , Enforcement Actions , Environmental Social & Governance (ESG) , Financial Reporting , Fines , Foreign Investment , HKEx , Hong Kong , Hong Kong Securities and Futures Commission (HKSFC) , Hong Kong Stock Exchange , Initial Public Offering (IPO) , Insider Information , Listing Rules , Mergers , Non-GAAP Financial Measures , Office of Foreign Assets Control (OFAC) , Publicly-Traded Companies , Risk Assessment , The Market Misconduct Tribunal (MMT) , Trade Suspensions , Variable Interest Entities